Professor, Medicine, University of Pittsburgh School of Medicine
Hematology
Dr. Robert L. Redner, MD
|
|
Give Review
Robert Redner practices Hematology. Dr. Robert L. Redner is also published. He has 47 publications published. The lastest publication: "ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.' Robert Redner accepts Medicare.
Publications
- An ATRActive future for differentiation therapy in AML.
- Extrinsic Apoptosis Is Impeded by Direct Binding of the APL Fusion Protein NPM-RAR to TRADD.
- STAT transcription factors in normal and Cancer stem cells.
- Interaction with RXR is necessary for NPM-RAR-induced Myeloid differentiation blockade.
- NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) Acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation.
- PRAMEing a Picture of Differentiation Therapy for AML?
- Fludarabine and cytarabine in patients with Acute myeloid leukemia refractory to two different courses of front-line chemotherapy.
- Cryptic insertion of PML-RARA into the 3p25 locus in an Acute promyelocytic leukemia with t(3;17)(p25;q21).
- Knee pain: ACL, MCL, or CML?
- Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of Acute promyelocytic leukemia.
- Why doesn't imatinib cure chronic myeloid Leukemia?
- Inhibition of Src family kinases enhances retinoic acid induced gene expression and Myeloid differentiation.
- Leukemia fusion proteins and co-repressor complexes: changing paradigms.
- Intensive chemotherapy in patients aged 70 years or older newly diagnosed with Acute myeloid leukemia.
- Studies on the control of antibody synthesis. XV. Effect of nonspecific immunodepression on antibody affinity.
- The long-term impact of nonprofessional service experience on college students.
- Others' perceptions of mothers of handicapped children.
- Nonprofessional counselors: revisiting selection and impact issues.
- Diversion of juvenile offenders: an experimental comparison.
- Variations on a theme: the alternate translocations in APL.
- The t(5;17) Acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcrip...
- Involvement of the MLL and RARalpha genes in a patient with Acute monocytic leukemia with t(11;17)(q23;q12)
- Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by Acute promye...
- Chromatin remodeling and Leukemia: new therapeutic paradigms.
- Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO Leukemia cells.
- ETO, fusion partner in t(8;21) Acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
- Isolated Deep cerebral venous thrombosis treated by direct endovascular thrombolysis.
- Differentiation of t(5;17) variant Acute promyelocytic leukemic blasts by all-trans retinoic acid.
- The t(5;17) variant of Acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
- A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in Acute promyelocytic leukemia (APML) with atypical features.
- An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic Cells and induces differentiation.
- Tumour-specific inhibition of Lymphoma growth by an antisense oligodeoxynucleotide.
- Patterns of infection in patients with aplastic Anemia and the emergence of Aspergillus as a major cause of death.
- Variable pattern of jun and fos gene expression in different hematopoietic Cell lines during interleukin 3-induced entry into the Cell cycle.
- A novel t(3;17)(p25;q21) variant translocation of Acute promyelocytic leukemia with rearrangement of the RARA locus.
- Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
- Dasatinib promotes ATRA-induced differentiation of AML Cells.
- Gefitinib potentiates Myeloid cell differentiation by ATRA.
- Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with Acute myeloid leukemia.
- Mitoxantrone and etoposide in patients with newly diagnosed Acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin.
- Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
- Improved quality of life for romiplostim-treated patients with Chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
- Effect of antacid on imatinib absorption.
- The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PML.
- Efficacy of romiplostim in patients with Chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
- Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed Acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
Schools
Harvard Medical School
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
UCLA Medical Center -
Johns Hopkins University
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1851367684 | |
| NPPES Provider LastName | REDNER | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 152321301 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 239.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851367684 |
| Last Name Of The Provider | REDNER |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Narinder K. Malhotra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel P. Petro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel C. Jankowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret Kennedy, MD |
|
|
Dr. Dong H. Kim, MD |
|
|
Dr. Michael J. O'Connell, MD |
|
|
Dr. Anna Margareta Johnsen, MD |
|
|
Dr. Hassane M. Zarour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Anna Kaminsky |